Lapatinib, it turns out, also inhibits the activity of a protein called the epidermal growthfactor receptor, which has been found to be important for stem-cell proliferation.
She said they were currently funding research into drugs that mimic the action of nerve growthfactor (NGF), the name given to the gene therapy involving stimulating cell function.